Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Novel Biomarkers in Chronic Airway Diseases

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009 by Chonbuk National University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Chonbuk National University
ClinicalTrials.gov Identifier:
NCT00849836
First received: February 23, 2009
Last updated: NA
Last verified: February 2009
History: No changes posted

February 23, 2009
February 23, 2009
February 2009
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Novel Biomarkers in Chronic Airway Diseases
The Study for The Identification of Novel Biomarkers in Chronic Airway Inflammatory Disorders

The purpose of this study is:

  • To define The differences of bio-chemical phenotypes in chronic airway inflammatory diseases.
  • To identify novel biomarkers in chronic airway inflammatory diseases as a screening, diagnostic, or monitoring marker.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Patients with acute exacerbation of asthma or COPD, patients with stable status of those disease, and the healthy control subjects

  • Asthma
  • COPD
Not Provided
  • Acute exacerbation
  • Stable disease
  • Healthy control
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
30
January 2010
Not Provided

Inclusion Criteria:

  • > 18 years olds
  • Both sexes
  • Asthma or COPD was diagnosed according to the criteria of the American Thoracic Society, GINA, GOLD guideline
  • Acute exacerbation was defined by the criteria of the American Thoracic Society, GINA, GOLD guideline
  • For stable disease, none of the subjects had received inhaled or oral corticosteroids or any other anti-inflammatory drugs, had an exacerbation history in the previous 6 months
Both
18 Years and older
Yes
Contact: So Ri Kim, MD, PhD 82-63-250-2475 sori@chonbuk.ac.kr
Contact: Yong Chul Lee, MD, PhD 82-63-250-1664 leeyc@chonbuk.ac.kr
Korea, Republic of
 
NCT00849836
RCPD
Not Provided
Yong Chul Lee, Chonbuk National University Medical School
Chonbuk National University
Not Provided
Not Provided
Chonbuk National University
February 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP